Background. Population/Intervention(s)/ Comparison/Outcome(s) (PICO) Treatment of psychostimulant dependence
|
|
- Allyson Morrison
- 8 years ago
- Views:
Transcription
1 updated 2012 Treatment f psychstimulant dependence Q3: Are pharmactherapies safe and effective fr the treatment f psychstimulant dependence (maintenance r relapse preventin) in nn-specialized settings? Backgrund Methadne, buprenrphine and naltrexne are knwn t be effective in the treatment f piid dependence. Their efficacy was recently examined in the Guidelines fr the Psychscially Assisted Pharmaclgical Treatment f Opiid dependence (WHO, 2009) and they are nt examined further here. Recent Cchrane reviews shw n effect f antipsychtics, antiepileptic r antidepressants in the treatment f stimulant dependence, althugh there has been interest in the use f dexamphetamines, disulfiram and naltrexne. A recent review f disulfiram fund n effect f disulfiram (de Lima, 2002). As there are n recent reviews f the ther tw medicatins, each f which are reviewed here. There are n medicatins cnsidered feasible fr the treatment f cannabis dependence reviewed here. The issue f benzdiazepine prescribing fr benzdiazepine dependence has nt been examined as the issue f gradual vs rapid withdrawal is cvered in the sectin n withdrawal frm benzdiazepines. Ppulatin/Interventin(s)/ Cmparisn/Outcme(s) (PICO) Ppulatin: Interventins: stimulant dependence (amphetamines, methamphetamines and ccaine) naltrexne dexamphetamine Cmparisn: Outcmes: placeb r treatment as usual stimulant use 1
2 psychscial utcmes adverse effects List f the systematic reviews identified by the search prcess INCLUDED IN GRADE TABLES OR FOOTNOTES Naltrexne fr stimulant dependence: New review by : Huynh N, & Clark N (2009, unpublished). Dexamphetamine fr stimulant dependence: New review by De Windt Mears J & Clark N (2009, unpublished). Narrative descriptin f the studies that went int the analysis Dexamphetamine fr stimulant dependence (ccaine and amphetamines and methamphetamines) A pilt randmized cntrlled study (n=41) f dexamphetamine substitutin in cmparisn t the standard f care fr amphetamine dependence fund that bth interventins reduced street amphetamine use (Shearer et al, 2001). The standard f care treatment, r cunseling, was ffered t all participants. The nly grup difference bserved was that the dexamphetamine grup were significantly mre likely t attend the cunseling and receiving twice as many sessins as the cntrl grup wh where set t receive cunseling nly. N serius adverse events were reprted in the treatment grup. Anther pilt randmized duble blind placeb-cntrlled study (n=30) f dexamphetamine fr ccaine dependence fund that the prprtin f ccainepsitive urine samples detected in the dexamphetamine grup declined cmpared t n changes in the placeb cntrl grup, althugh the grup differences was nt significant (Shearer et al, 2003). Three adverse events were nted requiring hspitalizatin: psychtic symptms and the tw ther were nt related t study participatin. Grabwski et al, 2001 cmpleted a duble-blind randmized study (n=128) f dexamphetamine fr ccaine dependence, which fund that there were fewer ccaine-psitive urine screens than the placeb grup after 3 mnths. Six subjects stated medicatin side effects as reasns fr drpping ut. Meta-analysis was nt pssible due t differences in treatment utcmes reprted and lack f reprting f standard deviatins f cntinuus measures. 2
3 Naltrexne fr stimulant dependence Hersh et al, 1998 cnducted a randmized, duble-blind, placeb-cntrlled study f Naltrexne (50mg/day) in 64 participants with cmrbid ccaine and alchl dependence during 8 weeks. They reprted 17 participants achieved cmplete abstinence frm ccaine fr the entire 8-week treatment perid, with n between-grup difference (X2=2.7, 1df). Furthermre, 29 participants were abstinent fr at least 2 cntinuus weeks fllwing randmizatin, with n between-grup difference (X2=0.8, 1df). A duble-blind, placeb-cntrlled study f Naltrexne (50mg) in 85 ccaine-dependent participants during 12 weeks, by Schmitz et al, 2001, fund n significant effect f Naltrexne n time t first ccaine-psitive urine. Hwever, there is a significant three-way interactin (functin f time, therapy and medicatin) indicates less ccaine use ver time amng subjects receiving Naltrexne. Overall, 14% f participants (n=12) abstrained frm ccaine cntinuusly ver the 12 weeks. Jayaram-Lindstrm et al, 2008 cnducted a randmized, placeb-cntrlled study f Naltrexne (50mg/day) in 80 participants with amphetamine dependence during 12 weeks. The results shwed that the Naltrexne grup differed in cntinuus abstinence rates (Brestlw test, t=6.36, p<.05) in favr f Naltrexne treatment. GRADE tables Table 1 Authr(s): Clark N Date: Questin: Shuld Naltrexne vs Placeb be used fr stimulant dependence? Settings: Bibligraphy: Hersh D, van Kirk JR, Kranzler HR (1998). Naltrexne treatment f cmrbid alchl and ccaine use disrders. Psychpharmaclgy (Berlin), 139: Jayaram-Lindström N et al (2008). Naltrexne fr the treatment f amphetamine dependence: a randmized, placeb-cntrlled trial. American Jurnal f Psychiatry, 165: Schmitz JM et al (2001). Naltrexne and relapse preventin treatment fr ccaine-dependent patients. Addictive Behavirs, 26: Schmitz JM et al (2004). Treatment f ccaine-alchl dependence with naltrexne and relapse preventin therapy. American Jurnal f Addictin, 13: Summary f findings Quality assessment N f patients Effect N f Design Limitatins Incnsistency Indirectness Imprecisin Other Naltrexne Placeb Relative Abslute Quality Imprtance 3
4 studies cnsideratins (95% CI) Percentage f negative urine samples (ITT analysis) (fllw-up mean 12 weeks; Better indicated by higher values) 4 1,2 randmized very very serius 4 serius 3 indirectness 5 imprecisin 6 % days stimulants nt used (self-reprts) (fllw-up 8-12 weeks; Better indicated by higher values) 3 1,7 randmized very serius 8 incnsistency 4 serius 10 indirectness 9 Abstinence (fllw-up mean 12 weeks; either abstinence fr the duratin f the study r 3 weeks cntinuus abstinence during the study) 3 7 randmized very serius 3 incnsistency 11 Severe Adverse Effects (fllw-up 8 weeks; Risk rati) 1 12 randmized serius 13 incnsistency 14 indirectness imprecisin serius 16 indirectness 15 30/123 (24.4%) /31 (6.5%) 17/127 (13.4%) 11/33 (33.3%) RR 1.83 (1.06 t 3.15) RR 0.19 (0.05 t 0.8) MD higher (12.89 t higher) MD 5.95 higher (0.64 lwer t higher) 111 mre per 1000 (frm 8 mre t 288 mre) 270 fewer per 1000 (frm 67 fewer t 317 fewer) VERY VERY CRITICAL Mild AE (# patients) (fllw-up 8-12 weeks; Risk rati) 1 1,7,17 randmized very serius 8 incnsistency indirectness serius 18 Mild AE (Mean # weekly events) (fllw-up mean 12 weeks; Better indicated by lwer values) 2 1,19 randmized Psychscial functin very serius 20 incnsistency 4 serius 22 indirectness 21 14/40 (35%) 0/40 (0%) RR 29 (1.79 t ) mre per 1000 (frm 0 mre t 0 mre) MD 0.3 higher (0.34 lwer t 0.94 higher) VERY VERY 0 n evidence 0 fewer per 1000 (frm 0 fewer 0/0 (0%) 0/0 (0%) Nt estimable CRITICAL available t 0 fewer) 1 Calculated using RevMan. 2 Jayaram-Lindstrm et al, 2008; Schmitz et al, 2004; Pettinati 2008; Schmitz et al, Jayaram-Lindstrm et al, 2008 study had adequate randmizatin, drp uts with 14/40 (35%) in placeb grup and 11/40 (28%) in naltrexne grup, utcme assessment masked adequately. Schmitz et al, 2004 study did nt describe the randmizatin methd, verall 66% drp ut rate. 4 I squared = 89%. 5 Schmitz et al, ccaine/alchl dependence. Jayaram-Lindstrm et al, amphetamine dependence. 6 n= Hersh et al, 1998; Jayaram-Lindstrm et al; 2008; Pettinati Jayaram-Lindstrm et al, 2008 study had adequate randmizatin, drp uts with 14/40 (35%) in placeb grup and 11/40 (28%) in naltrexne grup, utcme assessment masked adequately. Hersh et al, 1998 study did nt describe randmizatin methd, 29/64 (39%) drp uts. 9 Jayaram-Lindstrm et al, amphetamine dependence. Hersh et al, ccaine/alchl dependence. 10 Naltrexne n=123 and placeb n= I squared 28%. 12 Hersh et al, Hersh et al, 1998 study 29/64 (39%) drp uts. 4
5 14 Only 1 study. 15 ccaine/alchl dependence. 16 n = 64 and upper cnfidence limit crsses a risk f Jayaram-Lindstrm et al, n=120 and estimate with a cnfidence interval that crsses Schmitz et al, 2001 and Schmitz et al, 2004 study did nt describe the randmizatin methd, verall 66% drp ut rate. Schmitz et al, 2001 study did nt describe the randmizatin methd, 43/85(51%) drp uts. 21 Schmitz et al, ccaine/alchl dependence. Schmitz et al, ccaine dependence. 22 n=165 and SMD with a cnfidence interval that crsses 0. References Grabwski J et al (2001). Dextramphetamine fr ccaine-dependence treatment: a duble-blind randmized clinical trial. Jurnal f Clinical Psychpharmaclgy, 21: Hersh D, van Kirk JR, Kranzler HR (1998). Naltrexne treatment f cmrbid alchl and ccaine use disrders. Psychpharmaclgy (Berlin), 139: Jayaram-Lindström N et al (2008). Naltrexne fr the treatment f amphetamine dependence: a randmized, placeb-cntrlled trial. American Jurnal f Psychiatry, 165: Pettinati HM et al (2008). A duble blind, placeb-cntrlled trial that cmbines disulfiram and naltrexne fr treating c-ccurring ccaine and alchl dependence. Addictive Behaviurs, 33: Schmitz JM et al (2001). Naltrexne and relapse preventin treatment fr ccaine-dependent patients. Addictive Behavirs, 26: Schmitz JM et al (2004). Treatment f ccaine-alchl dependence with naltrexne and relapse preventin therapy. American Jurnal f Addictin, 13: Shearer J et al (2001). Pilt randmized cntrlled study f dexamphetamine substitutin fr amphetamine dependence. Addictin, 96: Shearer J et al (2003). Pilt randmized duble blind placeb-cntrlled study f dexamphetamine fr ccaine dependence. Addictin, 98: WHO (2009). Guidelines fr the psychscially assisted pharmaclgical treatment f piid dependence. Geneva, Wrld Health Organizatin. 5
6 Frm evidence t recmmendatins Factr Narrative summary f the evidence base Explanatin One ut f the three studies (n=178) f dexamphetamine prescribing all fund a reductin in stimulant drug use in the treatment arms, althugh meta-analysis was nt pssible due t incmplete data reprting. Dexamphetamine prescribing did nt appear t be assciated with significant side effects cmpared t placeb. The 5 studies (n=372) examining naltrexne fr stimulant dependence shwed weak evidence f an effect f naltrexne cmpared t placeb in reducing stimulant use and severe adverse events (psychsis). The effect was nt cnsistent, being absent in tw f the studies, but theless statistically significant in meta-analysis. The results were the same fr ccaine dependent and amphetamine dependent patients, and were cmbined in the meta-analysis. In three f the studies participants were als alchl dependent. Summary f the quality f evidence Balance f benefits versus harms Lw t very lw. A small number f small studies with sme methdlgical flaws. In the absence f ther medicatin fr amphetamine and ccaine dependence, naltrexne culd have significant benefits. The risk f harm frm naltrexne in nn piid dependent patients is lw. An evidence fr dexamphetamine benefit was nt fund, althugh the reprts f adverse effects in the studies are nt higher than placeb, dexamphetamine as a medicatin is abusable and knwn t induce adverse effects. Define the values and preferences including any variability and human rights issues Dexamphetamine prescriptin may be viewed as cntinuing the dependence n stimulants, regardless f the health impact. 6
7 Define the csts and resurce use and any ther relevant feasibility issues Recmmendatin(s) Neither medicatin are particularly expensive, but availability is limited in sme cuntries. Naltrexne is nt a difficult medicatin t use in primary care settings. Dexamphetamines can be abused and s prescriptin f dexamphetamine raises a number f Dexamphetamine shuld nt be ffered fr the treatment f stimulant use disrders in nn-specialized settings. Strength f recmmendatin: STRONG Update f the literature search June 2012 In June 2012 the literature search fr this scping questin was updated. The fllwing systematic reviews were fund t be relevant withut changing the recmmendatin: Brackins T, Brahm NC, Kissack JC. Treatments fr Methamphetamine Abuse : A Literature Review fr the Clinician. Jurnal f Pharmacy Practice : 541 riginally published nline 17 Nvember 201.1DOI: / Castells X, Casas M, Vidal X, Bsch R, Rncer C, Rams-Quirga JA, Capella D. Efficacy f central nervus system stimulant treatment fr ccaine dependence: a systematic review and meta-analysis f randmized cntrlled clinical. Addictin 2007, 102, di: /j x Krupitsky EM, Blkhina EA. Lng-acting dept frmulatins f naltrexne fr herin dependence: a review. Current Opinin in Psychiatry 2010, 23: Lbmaier PP, Kune N, Gssp M, Waal H. Naltrexne Dept Frmulatins fr Opiid and Alchl Dependence: A Systematic Review. CNS Neurscience & Therapeutics (2011), 17, di: /j x 7
8 Mannelli P, Peindl KS, Wu LT. Pharmaclgical enhancement f naltrexne treatment fr piid dependence: a review. Subst Abuse Rehabil June ; 2011(2): di: /sar.s15853 Minzzi S, Amat L, Vecchi S, Davli M, Kirchmayer U, Verster A. Oral naltrexne maintenance treatment fr piid dependence. Cchrane Database f Systematic Reviews 2011, Issue 4. Art.N.: CD DOI: / CD pub4. (New search fr studies and cntent updated (n change t cnclusins), published in Issue 4, 2011.) Westver AN, Halm EA. D prescriptin stimulants increase the risk f adverse cardivascular events?: A systematic review. BMC Cardivascular Disrders 2012, 12:41 di: /
Q2: What interventions are safe and effective for drug withdrawal (cannabis, amphetamines, cocaine, benzodiazepines, and inhalants)?
updated 2012 Management f drug withdrawal Q2: What interventins are safe and effective fr drug withdrawal (cannabis, amphetamines, ccaine, benzdiazepines, and inhalants)? Backgrund Cessatin f dependent
More informationOverview of Approaches, Cost Effectiveness, and Outcomes for Substance Use Disorder Treatment New Hampshire House Finance Presentation March 16, 2015
Overview f Appraches, Cst Effectiveness, and Outcmes fr Substance Use Disrder Treatment New Hampshire Huse Finance Presentatin March 16, 2015 The infrmatin in this dcument has been accessed frm the Natinal
More informationCHAPTER 3. PHARMACOLOGICAL TREATMENT
CHAPTER 3. PHARMACOLOGICAL TREATMENT 3.1 Pharmaclgical treatment f alchl and drug use disrders Rbert Ali The brad cntext f treatment Treatment f substance use disrders wrks and is cst-effective (Cartwright,
More informationATLAS on substance use (2010) Resources for the prevention and treatment of substance use disorders
INTRODUCTION Dimensins f psychactive substance use and dependence The use f alchl and ther psychactive substances alters bth the functin and, ultimately, the structure f the brain by the altered stimulatin
More informationState Opioid Prescribing Policy: Florida
State Opiid Prescribing Plicy: Flrida Pain Plicy and Regulatin: Flrida General Plicies f the Flrida Bards f Medicine and Ostepathic Medicine (Bards) The Bards recgnize that "cntrlled substances, including
More informationWatlington and Chalgrove GP Practice - Patient Satisfaction Survey 2011
Watlingtn and Chalgrve GP - Patient Satisfactin Survey 2011 Backgrund During ne week in Nvember last year patients attending either the Chalgrve r the Watlingtn surgeries were asked t cmplete a survey
More informationSESSION II DRUGS IN SOCIETY AND IN VEHICLE OPERATION
SESSION II DRUGS IN SOCIETY AND IN VEHICLE OPERATION SESSION II DRUGS IN SOCIETY AND IN VEHICLE OPERATION Upn successfully cmpleting this sessin the student will be able t: Define the term "drug" in the
More informationTYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS
FACT SHEET Hamiltn TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS CONTACT: Amber 212-266-0062 OVERVIEW Type 2 diabetes accunts fr 95% f the 25.8 millin diabetes cases in the U.S 1 Obesity is a majr independent
More informationFindings on Health Care Cost, Pricing and Reimbursement in Alaska 1 Excerpted from Annual Reports of the Alaska Health Care Commission
Findings n Health Care Cst, Pricing and Reimbursement in Alaska 1 Excerpted frm Annual Reprts f the Alaska Health Care Cmmissin 2011 Findings n Cst f Health Care in Alaska (2011 Annual Reprt) i Health
More informationNQF 0028: Preventive Care and Screening Measure Pair: a. Tobacco Use Assessment, b. Tobacco Cessation Intervention
NQF 0028: Preventive Care and Screening Measure Pair: a. Tbacc Use Assessment, b. Tbacc Cessatin Interventin Descriptin: Cre: Alt Cre: Specialty: Frequency: Every 2 years a. Percentage f patients aged
More informationResearch Findings from the West Virginia Virtual School Spanish Program
Research Findings frm the West Virginia Virtual Schl Spanish Prgram Funded by the U.S. Department f Educatin Cnducted by R0cKMAN ETAL San Francisc, CA, Chicag, IL, and Blmingtn, IN Octber 4, 2006 R0cKMAN
More informationSESSION II DRUGS IN SOCIETY AND IN VEHICLE OPERATION
SESSION II DRUGS IN SOCIETY AND IN VEHICLE OPERATION HS172 R01/11 1 SESSION II DRUGS IN SOCIETY AND IN VEHICLE OPERATION Upn successfully cmpleting this sessin the student will be able t: Define the term
More informationBrief Addiction Monitor (BAM) With Scoring & Clinical Guidelines DRAFT 11/02/2009
Brief Addictin Mnitr (BAM) With Scring & Clinical Guidelines DRAFT 11/2/29 Participant ID: Interviewer ID (Clinician Initials): Date: Methd f Administratin: Clinician Interview Self Reprt Phne Time Started:
More informationCourse Drugs of Abuse
Lecture Objective Template Curse Drugs f Abuse PHAR 4207 Spring 2015 Lecture #1 Date/time: 2/15/2015 Terminlgy f Drugs f Abuse Define cmmn terms assciate with drug abuse. Give examples f variables affecting
More informationInitiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement (NQF 0004)
Initiatin and Engagement f Alchl and Other Drug Dependence Treatment: (a) Initiatin, (b) Engagement (NQF 0004) EMeasure Name Initiatin and Engagement f Alchl and Other Drug Dependence Treatment: (a) Initiatin,
More informationDimethyl fumarate (Tecfidera ) Drug Formulary Review and Multiple Sclerosis Class Review
Oregn Regin Pharmacy and Therapeutic Cmmittee (ORPTC) August 9, 2013 Key Decisins in Acute Care Dimethyl fumarate (Tecfidera ) Drug Frmulary Review and Multiple Sclersis Class Review With the recent release
More informationMedical Coverage Policy Treatment of Opioid Dependence
Medical Cverage Plicy Treatment f Opiid Dependence Device/Equipment Drug Medical Surgery Test Other Effective Date: 07/05/2011 Plicy Last Updated: 6/3/2008 Prspective review is recmmended/required. Please
More informationStudent Learning Objectives Assessment Report Criminal Justice Program. June 1, 2015
Student Learning Objectives Assessment Reprt Criminal Justice Prgram June 1, 2015 Objectives & Curriculum Objective Mapping See attached revised Criminal Justice Assessment Mapping Tl (revised Spring 2014)
More informationHow can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users?
ACMD Advisry Cuncil n the Misuse f Drugs Hw can piid substitutin therapy (and drug treatment and recvery systems) be ptimised t maximise recvery utcmes fr service users? Octber 2015 ACMD RECOVERY COMMITTEE
More informationExecutive Summary DIABETES MELLITUS AND GLUCOSE CONTROL BIOTECHNOLOGY INNOVATION IN DIABETES: INSULIN ANALOGS EXECUTIVE SUMMARY
Executive Summary DIABETES MELLITUS AND GLUCOSE CONTROL Diabetes is widely acknwledged as an immense and grwing public health prblem. The disease is assciated with increased risk f death, decreased quality
More informationSALARY CONSIDERATIONS FOR CANCER REGISTRARS
SALARY CONSIDERATIONS FOR CANCER REGISTRARS UPDATED 2012 SURVEY DATA SALARY CONSIDERATIONS FOR CANCER REGISTRARS UPDATED 2012 SURVEY DATA Natinal Cancer Registrars Assciatin 1340 Braddck Place, Suite 203
More informationDoctoral Framework Guidelines
Dctral Framewrk Guidelines UTS Framewrk fr Dctral Educatin UTS Business Schl Higher Degree Research 1. Intrductin The UTS Framewrk fr Dctral Educatin is a UTS-wide initiative directed twards imprving the
More informationUpdated PT, OT, and ST Benefit Changes for Acute Services for Texas Medicaid Effective January 1, 2014
Updated PT, OT, and ST Benefit Changes fr Acute Services fr Texas Medicaid Effective January 1, 2014 Infrmatin psted December 31, 2013 Nte: This article applies t claims submitted t TMHP fr prcessing.
More informationCHAPTER 5. POLICY AND LEGISLATION
CHAPTER 5. POLICY AND LEGISLATION 5.1 Alchl and drug treatment plicy in public health perspective Rbin Rm Fr centuries, physicians, clergy and charity wrkers have prvided treatment r care fr habitual use
More informationEqual Pay Audit 2014 Summary
Equal Pay Audit 2014 Summary Abut the dcument The fllwing summary is an abridged versin f Ofcm s equal pay audit 2014. In the full versin f the reprt we set ut ur key findings, cmment n any issues arising
More informationtime needed to collect and analyse data.
Feasibility and Pilt studies This is a definitin that has been agreed by the Efficacy and Mechanism Evaluatin (EME), Public Health Research (PHR), Health Technlgy Assessment (HTA) and Research fr Patient
More informationChris Chiron, Interim Senior Director, Employee & Management Relations Jessica Moore, Senior Director, Classification & Compensation
TO: FROM: HR Officers & Human Resurces Representatives Chris Chirn, Interim Senir Directr, Emplyee & Management Relatins Jessica Mre, Senir Directr, Classificatin & Cmpensatin DATE: May 26, 2015 RE: Annual
More informationFIRST STEPS NUTRITION TRUST
FIRST STEPS NUTRITION TRUST Safety advice fr infant milk preparatin: Vacuum flasks, cmbined frmula mixer and bttle insulatr and milk preparatin machines. March 2015 This statement ffers advice t prfessinals
More informationWhat Does Specialty Own Occupation Really Mean?
What Des Specialty Own Occupatin Really Mean? Plicy definitins are cnfusing, nt nly t cnsumers but als t many f the insurance prfessinals wh sell them. Belw we will try t prvide an understandable explanatin
More informationSample Aggregate Review - Root Cause Analysis Stage 3 or 4 Pressure Ulcers Acquired After Admission (Adverse Event type 17)
Lack f effective multidisciplinary cllabratin n pressure ulcer Lack f clinical practice/knwledge Limited patient and family pressure ulcer educatin Lack f staff cmpetency related t pressure ulcer Decisin
More informationAHRQ DESIGN AN EVALUATION OF THREE AOA PROGRAMS CHRONIC DISEASE SELF MANAGEMENT PROGRAM EVALUATION DESIGN CONTRACT # HHSA290200710071T
AHRQ DESIGN AN EVALUATION OF THREE AOA PROGRAMS CHRONIC DISEASE SELF MANAGEMENT PROGRAM EVALUATION DESIGN CONTRACT # HHSA290200710071T CDSMP Evaluatin Design Technical Expert Panel (TEP) Cnference Call
More informationSuccession Planning & Leadership Development: Your Utility s Bridge to the Future
Successin Planning & Leadership Develpment: Yur Utility s Bridge t the Future Richard L. Gerstberger, P.E. TAP Resurce Develpment Grup, Inc. 4625 West 32 nd Ave Denver, CO 80212 ABSTRACT A few years ag,
More informationFINANCE SCRUTINY SUB-COMMITTEE
REPORT FOR: PERFORMANCE AND FINANCE SCRUTINY SUB-COMMITTEE Date f Meeting: 6 January 2015 Subject: Staff Survey and Sickness Absence Mnitring Results and Actin plans Respnsible Officer: Scrutiny Lead Member
More informationStandards and Procedures for Approved Master's Seminar Paper or Educational Project University of Wisconsin-Platteville Requirements
Standards and Prcedures fr Apprved Master's Seminar Paper r Educatinal Prject University f Wiscnsin-Platteville Requirements Guidelines Apprved by the Graduate Cuncil University f Wiscnsin-Platteville
More informationQ4: Are acamprosate, disulfiram and naltrexone safe and effective in preventing relapse in alcohol dependence in nonspecialized health care settings?
updated 2012 Preventing relapse in alcohol dependent patients Q4: Are acamprosate, disulfiram and naltrexone safe and effective in preventing relapse in alcohol dependence in nonspecialized health care
More informationCode Breaking who, what, when, how and why?
Cde Breaking wh, what, when, hw and why? June 2015 Outline What is blinding? Why are studies blinded? What is cde breaking? When wuld I want t cde break? Cde breaking in the event f a SUSAR Wh can cde
More informationStudent Academic Learning Services Page 1 of 7. Statistics: The Null and Alternate Hypotheses. A Student Academic Learning Services Guide
Student Academic Learning Services Page 1 f 7 Statistics: The Null and Alternate Hyptheses A Student Academic Learning Services Guide www.durhamcllege.ca/sals Student Services Building (SSB), Rm 204 This
More informationSpatial basis risk and feasibility of index based crop insurance in Canada: A spatial panel data econometric approach
Spatial basis risk and feasibility f index based crp insurance in Canada: A spatial panel data ecnmetric apprach Millin A.Tadesse (Ph.D.), University f Waterl, Statistics and Actuarial Science, Canada.
More informationCONTENTS UNDERSTANDING PPACA. Implications of PPACA Relative to Student Athletes. Institution Level Discussion/Decisions.
This dcument is intended t prvide NCAA member institutins with an infrmatinal guide regarding the ptential implicatins f the Patient Prtectin and Affrdable Care Act f 2010 (PPACA) when fully implemented
More informationMARYLAND MEDICAID: SUMMARY OF MENTAL HEALTH AND SUBSTANCE ABUSE BENEFITS
MARYLAND MEDICAID: SUMMARY OF MENTAL HEALTH AND SUBSTANCE ABUSE BENEFITS Key Ppulatins Cvered Diagnsis Cvered Under Specialty Mental Prvided n FFS Basis Thrugh Value ptins Specialty Mental Prvided n FFS
More informationConsolidated Edison of New York: Residential Direct Install Program: Process Evaluation Summary
Cnslidated Edisn f New Yrk: Residential Direct Install Prgram: Prcess Evaluatin Summary Evaluatin Cnducted by: DNV KEMA as subcntractr t Navigant Cnsulting PROGRAM SUMMARY March 13, 2013 Cn Edisn designed
More informationMarketing Consultancy Division (MCD) Export Consultancy Unit (ECU) Export in Focus. Export Market Expansion Strategies. Rabi-I, 1427 (April, 2006)
Marketing Cnsultancy Divisin (MCD) Exprt Cnsultancy Unit (ECU) Exprt in Fcus Exprt Market Expansin Strategies Rabi-I, 1427 (April, 2006) 1 Exprt Market Expansin Strategies Intrductin It is clear that glbalizatin
More informationDraft Specification for Comprehensive Diabetes Care for Individuals with SMI Page 1
Cmprehensive Diabetes Care fr Peple with Severe Mental Illness (based n HEDIS Cmprehensive Diabetes Care (nt NQF-endrsed) and Minnesta Cmmunity Measurement s Optimal Diabetes Care (NQF #0729)) Measure
More informationCMS Eligibility Requirements Checklist for MSSP ACO Participation
ATTACHMENT 1 CMS Eligibility Requirements Checklist fr MSSP ACO Participatin 1. General Eligibility Requirements ACO participants wrk tgether t manage and crdinate care fr Medicare fee-fr-service beneficiaries.
More informationExcellence in Mental Health Act Medicaid Pilot Program: Summary and Details
Excellence in Mental Health Act Medicaid Pilt Prgram: Summary and Details March 31, 2014 On March 31, 2014, Cngress passed the Prtecting Access t Medicare Act (H.R. 4302). This legislatin includes prvisins
More informationHow To Create A Veteran Prgram
Millin Veteran Prgram Part I: Develpment & Use f Database Jel Kupersmith, MD Chief Research & Develpment Officer Millin Veteran Prgram The Millin Veteran Prgram will create a genmic database ver 5-7 years
More informationBaltimore Conference Call with Director of Student Services 11-18-13
Baltimre Cnference Call with Directr f Student Services 11-18-13 80,000 students 85% FRL Cntent f Cde Had 26,000 suspensins per year --- had a 24% drp in Year 1 after Cde changed Suspensin nw used as last
More informationEJttilb Health. The University of Texas Medical Branch Audit Services. Audit Report. Epic In-Basket Management Audit. Engagement Number 2015-008
',. -... : t'f" ' EJttilb Health The University f Texas Medical Branch Audit Reprt Audit Engagement Number 2015-008 July 2015 nie University f Texas Medical Branch 301 University Bulevard, Suite 4.100
More informationPrinciples of Engagement with Universities providing accredited Actuarial Science programmes
The Actuarial Prfessin Principles f Engagement with Universities prviding accredited Actuarial Science prgrammes 1. What is an accredited actuarial science prgramme? Accreditatin f university prgrammes
More informationTraining Efficiency: Optimizing Learning Technology
Ideas & Insights frm 2008 Training Efficiency Masters Series Survey Results Training Efficiency: Optimizing Learning Technlgy trainingefficiency.cm Survey Results: Training Efficiency: Optimizing Learning
More informationProcess Improvement Center of Excellence Service Proposal Recommendation. Operational Oversight Committee Report Submission
Prcess Imprvement Center f Excellence Service Prpsal Recmmendatin Operatinal Oversight Cmmittee Reprt Submissin INTRODUCTION This Prpsal prvides initial infrmatin regarding a pssible additin t a service.
More informationTHE CITY UNIVERSITY OF NEW YORK IDENTITY THEFT PREVENTION PROGRAM
THE CITY UNIVERSITY OF NEW YORK IDENTITY THEFT PREVENTION PROGRAM 1. Prgram Adptin The City University f New Yrk (the "University") develped this Identity Theft Preventin Prgram (the "Prgram") pursuant
More informationStage 2 Meaningful Use - Core Measure 12 Patient Reminders Configuration Guide
Enterprise EHR Stage 2 Meaningful Use - Cre Measure 12 Patient Reminders Cnfiguratin Guide Last Updated: Nvember 8, 2013 Cpyright 2013 Allscripts Healthcare, LLC. www.allscripts.cm MU Cre 12 Send Patient
More informationBakersfield College Program Review Annual Update
Bakersfield Cllege Prgram Review Annual Update I. Prgram Infrmatin: Prgram Name: Prgram Type: Instructinal Nn Instructinal Prgram Missin Statement: The missin f the Bakersfield Cllege Human Services Prgram
More informationHonours in Psychological Sciences
Hnurs in Psychlgical Sciences (Mst f this is thanks t Stephen Bwden) Mst f it will be in the 4 th year manual when it is finalised (very snish) Curse structure a cmpulsry riginal supervised research prject
More informationJOINT COMMITTEE ON HEALTH & CHILDREN- THURSDAY 22 JANUARY 2015 OPENING REMARKS, SIMON KAYLL, CEO, MEDICAL PROTECTION SOCIETY
THE CHALLENGES FACING THE MEDICAL PROFESSION ARISING OUT OF THE HIGH COST OF PROFESSIONAL MEDICAL INDEMNITY INSURANCE AND HOW THESE CHALLENGES ARE BEING MET JOINT COMMITTEE ON HEALTH & CHILDREN- THURSDAY
More informationReport to the Health and Human Services Interim Committee and Social Services Appropriations Subcommittee
Reprt t the Health and Human Services Interim Cmmittee and Scial Services Apprpriatins Subcmmittee Expansin f 340B Drug Pricing Prgrams Vlume 18 Prepared by the Divisin f Medicaid and Health Financing
More informationPOLISH STANDARDS ON HEALTH AND SAFETY AS A TOOL FOR IMPLEMENTING REQUIREMENTS OF THE EUROPEAN DIRECTIVES INTO THE PRACTICE OF ENTERPRISES
POLISH STANDARDS ON HEALTH AND SAFETY AS A TOOL FOR IMPLEMENTING REQUIREMENTS OF THE EUROPEAN DIRECTIVES INTO THE PRACTICE OF ENTERPRISES M. PĘCIŁŁO Central Institute fr Labur Prtectin ul. Czerniakwska
More informationKnowledge and Perceptions of Cord Blood Donation among Pregnant Women
Knwledge and Perceptins f Crd Bld Dnatin amng Pregnant Wmen Crd bld is cllected frm an infant s umbilical crd after delivery. This methd pses n risk t the mther r infant. Mst ften the cells are discarded
More informationIAPT positive practice guide for working with people who use drugs and alcohol
IAPT psitive practice guide fr wrking with peple wh use drugs and alchl Intrductin 1. This guide seeks t assist IAPT teams and substance misuse services t wrk cnfidently and inclusively with thse wh have
More informationTitle IV Refund Policy (R2T4)
Title IV Refund Plicy (R2T4) Charter Oak State Cllege s revised Refund Plicy cmplies with the amended 34 CFR Sectin 668.22 f the Higher Educatin Amendment f 1998. This plicy reflects new regulatins that
More information- MATHEMATICS AND COMPUTER EDUCATION-
- MATHEMATICS AND COMPUTER EDUCATION- TRADITIONAL VS. ONLINE HOMEWORK IN COLLEGE ALGEBRA Kimberly Jrdan Burch and Yu-Ju Ku Mathematics Department 316 Stright Hall Indiana University f Pennsylvania Indiana,
More informationPhi Kappa Sigma International Fraternity Insurance Billing Methodology
Phi Kappa Sigma Internatinal Fraternity Insurance Billing Methdlgy The Phi Kappa Sigma Internatinal Fraternity Executive Bard implres each chapter t thrughly review the attached methdlgy and plan nw t
More informationNHS Citizen Assembly Stocktake (March 2015) Mental health and parity of esteem. Version 1
NHS Citizen Assembly Stcktake (March 2015) Mental health and parity f esteem Versin 1 1 Mental health and parity f esteem Parity f Esteem Objective 1. In line with the cmmitment in the Mandate, 2013 t
More informationUnemployment, Gold, Money and Forecasts of Inflation
Carnegie Melln University Research Shwcase @ CMU Tepper Schl f Business 3-1996 Unemplyment, Gld, Mney and Frecasts f Inflatin Allan H. Meltzer Carnegie Melln University, am05@andrew.cmu.edu Fllw this and
More informationMedication Guide. AUBAGIO (oh-bah-gee-oh) (teriflunomide) tablets
Medicatin Guide AUBAGIO (h-bah-gee-h) (teriflunmide) tablets Read this Medicatin Guide befre yu start using AUBAGIO and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationCalifornia DSRIP 2.0 Recommendations for Domain 4: Prevention
Califrnia DSRIP 2.0 Recmmendatins fr Dmain 4: Preventin 1. Brad Recmmendatins a. Leverage the State f Califrnia s recent effrts related t preventin Frm the Let s Get Healthy Califrnia Reprt and the wrk
More informationDampier Bunbury Pipeline (DBP)
Limited ABN 59 001 777 591 AFSL 232497 April 2011 (Update) Cst f Debt Summary Paper Dampier Bunbury Pipeline (DBP) IMPORTANT NOTE Nte 1 This dcument has been prepared by AMP Capital Investrs Limited (AMP
More informationFREE TO BREATHE ACCELERATE CLINICAL TRIALS GRANT REQUEST FOR APPLICATIONS
AWARD OVERVIEW FREE TO BREATHE ACCELERATE CLINICAL TRIALS GRANT REQUEST FOR APPLICATIONS Free t Breathe has a new funding pprtunity fcused n research t investigate strategies and interventins t increase
More informationTakeMeFishing.org Website Effectiveness Topline Findings October 12, 2010
TakeMeFishing.rg Website Effectiveness Tpline Findings Octber 12, 2010 Fishing/Bating Frequencies Nearly all visitrs and nn-visitrs t TakeMeFishing.rg reprted having gne fishing as an adult. Apprximately
More informationOverview of the Final Requirements for Meaningful Use - 2015 through 2017
Overview f the Final Requirements fr Meaningful Use - 2015 thrugh 2017 On Oct. 6, 2015, the Centers fr Medicare & Medicaid Services (CMS) issued a final rule utlining the requirements fr eligible prfessinal
More information2014 Clinical Quality Measures Tipsheet Last Updated: August, 2012
2014 Clinical Quality Measures Tipsheet Last Updated: August, 2012 Criteria fr Reprting Clinical Quality Measures 1. Medicare EHR Incentive Prgram Beginning in 2014, the reprting f clinical quality measures
More informationTrends and Considerations in Currency Recycle Devices. What is a Currency Recycle Device? November 2003
Trends and Cnsideratins in Currency Recycle Devices Nvember 2003 This white paper prvides basic backgrund n currency recycle devices as cmpared t the cmbined features f a currency acceptr device and a
More informationMedical Management. At a Glance 2. When to Notify Medical Management 3. Procedures Requiring Predetermination 4. Care Management Services 5
Medical Management At a Glance 2 When t Ntify Medical Management 3 Prcedures Requiring Predeterminatin 4 Care Management Services 5 Abut Identifi TM 5 Cmplex Care Management 6 Maternity Prgram 8 Medical
More informationAnnex 3. Specification of requirement. Surveillance of sulphur-emissions from ships in Danish waters
Annex 3 Specificatin f requirement Surveillance f sulphur-emissins frm ships in Danish waters 1 Cntent 1 Objective... 3 2 Prject Perid... 4 3 Psitin and Planning f Measurements... 4 3.1 Mnitring frm a
More informationStatistical Analysis (1-way ANOVA)
Statistical Analysis (1-way ANOVA) Cntents at a glance I. Definitin and Applicatins...2 II. Befre Perfrming 1-way ANOVA - A Checklist...2 III. Overview f the Statistical Analysis (1-way tests) windw...3
More information7 October 2011. Re: Themed Inspection into Third Party Personal Injury Claims. Dear
7 Octber 2011 Re: Themed Inspectin int Third Party Persnal Injury Claims Dear During 2011 the Central Bank f Ireland ( Central Bank ) undertk a themed inspectin prject in relatin t the prcessing f third
More informationHybrid Course Design and Instruction Guidelines
Hybrid Curse Design and Instructin Guidelines Terminlgy There are n standard definitins fr what cnstitutes a hybrid curse, but sme generally accepted descriptins fllw. In nline learning literature (and
More informationGroup Income Protection (GIP) Claim Case Studies
www.gruprisk.rg.uk Grup Incme Prtectin (GIP) Claim Case Studies What is GIP? GIP is a plicy taken ut by emplyers t cver their prmise t prvide sick pay t emplyees if illness r injury prevents them wrking
More informationServices and Medicaid in the OASAS Treatment System
Services and Medicaid in the OASAS Treatment System Arlene Gnzález-Sánchez, Cmmissiner Rbert Kent, General Cunsel General Patient Statistics 261,775 unique individuals were treated in the OASAS system
More information1 Last updated: 12/11/12
Overview: Online Curse Delivery Factrs In a face-t-face curse, all instructin takes place in the classrm. The learning management system (LMS, e.g., Mdle/LATTE) may be used t huse supplemental curse materials
More informationData Protection Act Data security breach management
Data Prtectin Act Data security breach management The seventh data prtectin principle requires that rganisatins prcessing persnal data take apprpriate measures against unauthrised r unlawful prcessing
More informationQuestions and Answers from Webinar: Medication Assisted Treatment: Special Anti-Discrimination Issues
Questins and Answers frm Webinar: Medicatin Assisted Treatment: Special Anti-Discriminatin Issues NOTE: We answered a substantial number f the questins received; hwever, we did nt answer questins that
More informationWHAT SHOULD I LOOK FOR WHEN I BUY HEALTH INSURANCE?
WHAT SHOULD I LOOK FOR WHEN I BUY HEALTH INSURANCE? The Maine Bureau f Insurance 34 State Huse Statin Augusta, Maine 04333 207-624-8475 r 1-800-300-5000 (in Maine) http://www.maine.gv/pfr/insurance Paul
More informationDRUG, ALCOHOL AND SUBSTANCE MISUSE POLICY FOR THE WORKPLACE
DRUG, ALCOHOL AND SUBSTANCE MISUSE POLICY FOR THE WORKPLACE Intrductin Write yur business name here recgnises that drug, alchl and substance misuse are grwing scial and medical prblems, which can lead
More informationThe Family Cost Share system is designed so families with the ability to pay will share in the cost of services.
Paying fr Early Childhd Interventin Services What is ECI? Texas Early Childhd Interventin (ECI) prgrams serve families with children birth t 36 mnths with develpmental delays r disabilities. ECI prvides
More informationRI Student Loan Authority
RI Student Lan Authrity Executive Summary f Strategic Plan Apprved by RISLA Bard f Directrs Octber 17, 2014 Missin Statement: Cnsistent with the authrity granted by the General Assembly f the State f Rhde
More informationThe Long-Term Use of Eszopiclone in the Elderly
The Lng-Term Use f Eszpiclne in the Elderly Image frm: http://allcarehh.cm/sleeping-well-as-yu-age/ Wanjiku Mwangi, Pharm.D. PGY-1 Cmmunity Pharmacy Practice Resident H-E-B Pharmacy/The University f Texas
More informationAudit Committee Charter. St Andrew s Insurance (Australia) Pty Ltd St Andrew s Life Insurance Pty Ltd St Andrew s Australia Services Pty Ltd
Audit Cmmittee Charter St Andrew s Insurance (Australia) Pty Ltd St Andrew s Life Insurance Pty Ltd St Andrew s Australia Services Pty Ltd Versin 2.0, 22 February 2016 Apprver Bard f Directrs St Andrew
More informationDr. Vernique Mirn, PhD. The University of Edinburgh (MRC) And MS
NEW STRATEGY FOR BRAIN REPAIR IN MULTIPLE SCLEROSIS By Dr. Vernique Mirn, Ph.D. Pstdctral fellw, MRC Centre fr Regenerative Medicine, The University f Edinburgh www.crm.ed.ac.uk Multiple sclersis is caused
More informationRepeat workers compensation claims: risk factors, costs and work disability Dr Rasa Ruseckaite & Dr Alex Collie
Repeat wrkers cmpensatin claims: risk factrs, csts and wrk disability Dr Rasa Ruseckaite & Dr Alex Cllie Institute fr Safety, Cmpensatin and Recvery Research Why lk at repeat claims? Why lk at repeat claims?
More informationOverview of the CMS Modification to Meaningful Use 2015 through 2017
Overview f the CMS Mdificatin t Meaningful Use 2015 thrugh 2017 On April 10, 2015, the Centers fr Medicare & Medicaid Services (CMS) issued a new prpsed rule fr the Medicare and Medicaid EHR Incentive
More informationWORKING P A P E R. Veterans Health Administration Mental Health Program Evaluation Technical Manual
WORKING P A P E R Veterans Health Administratin Mental Health Prgram Evaluatin Technical Manual MARCELA HOROVITZ-LENNON, KATHERINE E.WATKINS, HAROLD ALAN PINCUS, LISA R. SHUGARMAN, BRAD SMITH, TERYN MATTOX,
More informationBrief Heart Rate Variability Biofeedback for. Chrys Kim & David Eddie
Brief Heart Rate Variability Bifeedback fr Yung Adults Receiving Inpatient Treatment fr Substance Use Disrders Chrys Kim & David Eddie AAPB Prtland, May 16, 2013 Intrductin Substance use disrders (SUDs)
More informationHearing Loss Regulations Vendor information pack
Hearing Lss Regulatins Vendr infrmatin pack Nvember 2010 Implementing the Accident Cmpensatin (Apprtining Entitlements fr Hearing Lss) Regulatins 2010 The Minister fr ACC, the Hn. Dr Nick Smith, has annunced
More informationMy Academic Requirements and Degree Audit Report (pdf) Field Descriptions
My Academic s and Degree Audit Reprt Field Descriptins My Academic s and Degree Audit Reprt (pdf) Field Descriptins Imprtant Infrmatin Field descriptins f bth the nline My Academic s reprt and the Degree
More informationCHAPTER 1. PSYCHOACTIVE SUBSTANCE USE: EPIDEMIOLOGY AND BURDEN OF DISEASE
CHAPTER 1. PSYCHOACTIVE SUBSTANCE USE: EPIDEMIOLOGY AND BURDEN OF DISEASE 1.1 Alchl Jürgen Rehm and Jayadeep Patra Alchl is pssibly the ldest psychactive substance used by mankind (McGvern, 2009). Currently,
More informationDALBAR Due Diligence: Trust, but Verify
BEST INTEREST INVESTMENT RECOMMENDATIONS Advisr Rle under Best Interest Regulatins January 27, 2016 In the era when the cntractual bligatin is t act in the client s best interest, investment decisins can
More informationChange Management Process
Change Management Prcess B1.10 Change Management Prcess 1. Intrductin This plicy utlines [Yur Cmpany] s apprach t managing change within the rganisatin. All changes in strategy, activities and prcesses
More informationPay Strategy for Country- Appointed Staff
Pay Strategy fr Cuntry- Appinted Staff Cntents Overview...3 Audience...3 Respnsibilities...3 Glssary...3 Crprate pay philsphy...3 Plicy...4 Perfrmance-related pay...5 Cmmunicating pay infrmatin t staff...5
More information